The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > TRANSGENE S.A.

TRANSGENE S.A.
Nasdaq: TRGNY
Change
symbol:
     
 PROFILE
TRANSGENE's expertise in gene therapy may help it transform into a cancer fighter. The biotech company is focusing its R&D efforts on its two most promising cancer vaccine candidates. One of the products uses two antigens from the Human Papilloma Virus to treat cervical cancer, while the other candidate targets breast, lung, prostate, lung, and other cancers. In addition to these two projects, TRANSGENE is developing two immune therapy adjuvants that are injected directly into tumors, as well as other cancer immunotherapy products. The firm is seeking partners to take over development of its muscular dystrophy and cardiovascular gene therapy candidates. bioMérieux-Pierre Fabre owns more than half of TRANSGENE.

 COMPETITION
Cell Genesys, Inc. (CEGE)
GenStar Therapeutics Corporation (GNT)
Targeted Genetics Corporation (TGEN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 55.00
1-Yr. Sales Growth: 1,150.0%

 KEY PEOPLE
• Gilles Bélanger
    CEO
• Paul Bikard
    CFO

 CONTACT INFO
11, rue de Molsheim
67082 Strasbourg Cedex, France
Phone: 33-3-88-27-91-21
Fax: 33-3-88-27-91-11
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001